Search results for: 'ne02 generation diagnostic market'

2023 was a record-breaking year for power generation investment, with $864.6 billion committed to global projects. Climate obligations and supportive regulations are the mainstays of global growth. While China has significantly increased its renewable targets in recent years (partly to support domestic technology companies), the US' Inflation Reduc...

This research service offers a comprehensive analysis of the global oncology biomarker diagnostics market, which has transformed with the convergence of clinical demand, advances in technology, and strategic collaborations/partnerships coupled with precision medicine initiatives. It categorizes the market by technology (omics, immunoassays, bioinfo...

The global clinical diagnostics market is poised for strong growth, driven by increased adoption of advanced diagnostics technologies, greater investment in laboratories, and improved access to molecular and immunodiagnostic testing facilities. In 2025, the industry continued its transformation, establishing testing systems as intelligent systems...

This study presents a strategic overview of the evolving global energy landscape and identifies 20 companies poised to shape the future of power generation. It highlights the relationship between innovation, integration, and sustainability as the industry adapts to transformative megatrends, disruptive technologies, and geopolitical uncertainties.T...

This Frost & Sullivan analysis examines the increasing demand for generator services due to the growing need for generators in the commercial and industrial sectors as well as the factors that will drive or limit the market in the next ten years. The demand for power and the growing awareness among customers about the advantages of digital solution...

This Frost & Sullivan research service discusses advances in AI integration in Molecular Diagnostics, highlights key advantages of incorporating AI in the diagnostics workflow and roadblocks that have prevented it from becoming mainstream. While AI is widely used in radiology- and pathology-based diagnostics, its adoption is gradually increasing in...

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, presenting opportunities for innovation. There has been a...

According to the National Institute of Health (NIH), there are more than 80 types of autoimmune diseases, of which less than 30 are diagnosable. Being 1 of the top 10 causes of death in the United States, there is a critical need in the market for the diagnosis and the treatment of both systemic diseases, such as lupus and rheumatoid arthritis, as ...

The global generator database monitors and forecasts growth opportunities and analyzes the growth outlook for applications and end-user segments. Revenue and unit forecasts in key performance areas, regions to consider for future investment, and growth strategies that will get companies ahead of the competition are also covered. The database co...